High-dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer.

被引:45
作者
Lippman, ME [1 ]
机构
[1] Georgetown Univ, Med Ctr, Vincent T Lombardi Canc Res Ctr, Washington, DC 20007 USA
关键词
D O I
10.1056/NEJM200004133421508
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1119 / 1120
页数:2
相关论文
共 7 条
[1]  
Antman KH, 1999, J CLIN ONCOL, V17, P30
[2]   Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-22 [J].
Fisher, B ;
Anderson, S ;
Wickerham, DL ;
DeCillis, A ;
Dimitrov, N ;
Mamounas, E ;
Wolmark, N ;
Pugh, R ;
Atkins, JN ;
Meyers, FJ ;
Abramson, N ;
Wolter, J ;
Bornstein, RS ;
Levy, L ;
Romond, EH ;
Caggiano, V ;
Grimaldi, M ;
Jochimsen, P ;
Deckers, P .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) :1858-1869
[3]   Patient selection in high-dose chemotherapy trials: Relevance in high-risk breast cancer [J].
GarciaCarbonero, R ;
Hidalgo, M ;
PazAres, L ;
Calzas, J ;
Gomez, H ;
Guerra, JA ;
Hitt, R ;
Hornedo, J ;
Colomer, R ;
CortesFunes, H .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (10) :3178-3184
[4]  
GRADY D, 2000, NY TIMES 0205, P9
[5]  
HENDERSON IC, 1998, P AN M AM SOC CLIN, V17, pA101
[6]   Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer [J].
Rahman, ZU ;
Frye, DK ;
Buzdar, AU ;
Smith, TL ;
Asmar, L ;
Champlin, RE ;
Hortobagyi, GN .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (10) :3171-3177
[7]   Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. [J].
Stadtmauer, EA ;
O'Neill, A ;
Goldstein, LJ ;
Crilley, PA ;
Mangan, KF ;
Ingle, JN ;
Brodsky, I ;
Martino, S ;
Lazarus, HM ;
Erban, JK ;
Sickles, C ;
Glick, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (15) :1069-1076